Cannon Global Investment Management, LLC
Source: SEC Form 13F · as of Mar 2026Cannon Global Investment Management, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $10.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$10.7M
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 34,000 | $1.8M |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 2,800 | $1.5M |
| QGENQIAGEN N.V. | 34,400 | $1.4M |
| RVMDREVOLUTION MEDICINES, INC. | 8,500 | $827K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 2,400 | $794K |
| ABVXAbivax SA | 6,000 | $668K |
| KNSAKiniksa Pharmaceuticals International, plc | 11,000 | $530K |
| CTMXCytomX Therapeutics, Inc. | 96,100 | $452K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 5,100 | $428K |
| RNAAtrium Therapeutics Inc. | 25,087 | $335K |
| TBPHTheravance Biopharma, Inc. | 16,047 | $260K |
| BCRXBIOCRYST PHARMACEUTICALS INC | 26,600 | $253K |
| DMRADamora Therapeutics, Inc. | 9,300 | $241K |
| IVVDInvivyd, Inc. | 161,000 | $209K |
| VORVor Biopharma Inc. | 11,700 | $209K |
| QUREuniQure N.V. | 12,200 | $199K |
| CBIOCRESCENT BIOPHARMA, INC. | 10,200 | $187K |
| OCGNOcugen, Inc. | 70,000 | $127K |
| IPSCCentury Therapeutics, Inc. | 49,000 | $111K |
| NERVMinerva Neurosciences, Inc. | 17,758 | $107K |
| OBIOOrchestra BioMed Holdings Inc. | 22,607 | $96K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.